Associations between illness beliefs, medication beliefs, anticoagulation‐related quality of life, and INR control: Insights from the Switching Study

Anticoagulation control with vitamin‐K antagonists (VKAs) in patients with atrial fibrillation (AF) or venous thromboembolism (VTE) can be measured using time in therapeutic range (TTR), where TTR >65% is considered good and low TTR may be associated with low adherence. This cross‐sectional obser...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Research and practice in thrombosis and haemostasis 2018-07, Vol.2 (3), p.497-507
Hauptverfasser:	Bartoli‐Abdou, John K., Patel, Jignesh P., Xie, Rosa, Dzahini, Olubanke, Vadher, Bipin, Brown, Alison, Roberts, Lara N., Patel, Raj K., Arya, Roopen, Auyeung, Vivian
Format:	Artikel
Sprache:	eng
Schlagworte:	adherence anticoagulation atrial fibrillation Chronic illnesses Cluster analysis Hematologi Hematology illness belief Likert scale medication beliefs medicines Original Original : Thrombosis Patients pulmonary-embolism Quality of life risk stratification Studies therapy thromboembolism time in time in therapeutic range validation Variables venous thromboembolism vitamin-k antagonists warfarin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Anticoagulation control with vitamin‐K antagonists (VKAs) in patients with atrial fibrillation (AF) or venous thromboembolism (VTE) can be measured using time in therapeutic range (TTR), where TTR >65% is considered good and low TTR may be associated with low adherence. This cross‐sectional observational study compared illness beliefs, treatment beliefs, and treatment satisfaction of patients with TTR >75% and TTR 75% and 214 with TTR 75% patients had been taking warfarin on average over 2 years longer than TTR
ISSN:	2475-0379 2475-0379
DOI:	10.1002/rth2.12116